UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Herpud1 negatively regulates pathological cardiac hypertrophy by inducing IP3 receptor degradation

Torrealba, Natalia; Navarro-Marquez, Mario; Garrido, Valeria; Pedrozo, Zully; Romero, Diego; Eura, Yuka; Villalobos, Elisa; ... Lavandero, Sergio; + view all (2017) Herpud1 negatively regulates pathological cardiac hypertrophy by inducing IP3 receptor degradation. Scientific Reports , 7 , Article 13402. 10.1038/s41598-017-13797-z. Green open access

[thumbnail of Herpud1 negatively regulates pathological cardiac hypertrophy by inducing IP3 receptor degradation.pdf]
Preview
PDF
Herpud1 negatively regulates pathological cardiac hypertrophy by inducing IP3 receptor degradation.pdf - Published Version

Download (4MB) | Preview

Abstract

Cardiac hypertrophy is an adaptive response triggered by pathological stimuli. Regulation of the synthesis and the degradation of the Ca2+ channel inositol 1,4,5-trisphosphate receptor (IP3R) affects progression to cardiac hypertrophy. Herpud1, a component of the endoplasmic reticulum-associated degradation (ERAD) complex, participates in IP3R1 degradation and Ca2+ signaling, but the cardiac function of Herpud1 remains unknown. We hypothesize that Herpud1 acts as a negative regulator of cardiac hypertrophy by regulating IP3R protein levels. Our results show that Herpud1-knockout mice exhibit cardiac hypertrophy and dysfunction and that decreased Herpud1 protein levels lead to elevated levels of hypertrophic markers in cultured rat cardiomyocytes. In addition, IP3R levels were elevated both in Herpud1-knockout mice and Herpud1 siRNA-treated rat cardiomyocytes. The latter treatment also led to elevated cytosolic and nuclear Ca2+ levels. In summary, the absence of Herpud1 generates a pathological hypertrophic phenotype by regulating IP3R protein levels. Herpud1 is a novel negative regulator of pathological cardiac hypertrophy.

Type: Article
Title: Herpud1 negatively regulates pathological cardiac hypertrophy by inducing IP3 receptor degradation
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s41598-017-13797-z
Publisher version: https://doi.org/10.1038/s41598-017-13797-z
Language: English
Additional information: © The Author(s), 2025. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/
Keywords: Cardiac hypertrophy, Cell signalling
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Neurosciences Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10213202
Downloads since deposit
1Download
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item